Valuation: DexCom, Inc.

Market Cap 30.94B 27.65B 25.39B 23.06B 43.31B 2,931B 44.4B 303B 122B 1,547B 116B 114B 4,904B P/E 2026 *
32.6x
P/E 2027 * 27.5x
Enterprise Value 30.6B 27.34B 25.11B 22.81B 42.83B 2,899B 43.91B 300B 121B 1,530B 115B 112B 4,849B EV / Sales 2026 *
5.85x
EV / Sales 2027 * 5.21x
Free-Float
90.14%
Yield 2026 *
-
Yield 2027 * -
1 day-2.11%
1 week+5.60%
Current month+0.83%
1 month-2.80%
3 months-0.58%
6 months+35.24%
Current year+25.01%
1 week 77.69
Extreme 77.69
85.24
1 month 76.52
Extreme 76.52
88.87
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 31/12/2025
Director of Finance/CFO 46 18/03/2021
Chief Tech/Sci/R&D Officer - 30/04/2024
Director TitleAgeSince
Chairman 68 29/07/2018
Director/Board Member 67 19/11/2009
Director/Board Member 47 31/12/2025
Date Insider Type Main position Quantity % Market Cap. Importance
28/09/26 Sell

Head of Human Resources

-2,565 0.0007%
15/09/26 Sell

Compliance Officer

-1,700 0.0005%
15/09/26 Sell

Director

-6,539 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-2.11%+5.60%+42.51%-11.42% 31.61B
-0.69%+4.31%-11.50%+14.01% 191B
-0.41%+4.31%+9.02%+37.16% 122B
+1.22%+1.44%-12.83%+11.62% 117B
-1.42%+5.29%-41.93%+4.94% 96.21B
+0.79%+3.18%+0.80%+77.18% 64.47B
-5.48%-5.11%-1.24%+61.88% 52.51B
-0.22%+0.91%+10.89%-22.57% 54.1B
+0.06%+17.86%+6.76%+60.22% 52.91B
-0.96%+3.24%+0.07%-9.20% 35.65B
Average -0.86%+4.27%+0.25%+22.38% 81.64B
Weighted average by Cap. -0.50%+4.10%-5.33%+22.68%

Financials

2026 *2027 *
Net sales 5.23B 4.67B 4.29B 3.9B 7.32B 495B 7.5B 51.21B 20.6B 261B 19.62B 19.2B 828B 5.77B 5.15B 4.74B 4.3B 8.08B 547B 8.28B 56.52B 22.74B 288B 21.66B 21.19B 914B
Net income 978M 874M 803M 729M 1.37B 92.63B 1.4B 9.58B 3.85B 48.89B 3.67B 3.59B 155B 1.14B 1.02B 933M 847M 1.59B 108B 1.63B 11.14B 4.48B 56.85B 4.27B 4.18B 180B
Net Debt -343M -307M -282M -256M -481M -32.54B -493M -3.36B -1.35B -17.17B -1.29B -1.26B -54.43B -888M -793M -728M -662M -1.24B -84.08B -1.27B -8.69B -3.5B -44.38B -3.33B -3.26B -141B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
03/11/26 US$82.97 -2.11% 4,114,565
02/11/26 US$84.76 +3.00% 4,063,157
30/10/26 US$82.29 +2.95% 8,637,526
29/10/26 US$79.93 +1.67% 5,923,570
28/10/26 US$78.62 +0.08% 5,371,695
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
82.97USD
Average target price
98.15USD
Spread / Average Target
+18.30%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.
  1. Stock Market
  2. Stocks
  3. DXCM Stock